An official American Thoracic Society Statement: pulmonary hypertension phenotypes - Wikidata - wikimedia - TriplyDB

An official American Thoracic Society Statement: pulmonary hypertension phenotypes

An official American Thoracic Society Statement: pulmonary hypertension phenotypes

http://www.wikidata.org/entity/Q34919733

about

Challenges and Current Efforts in the Development of Biomarkers for Chronic Inflammatory and Remodeling Conditions of the Lungs The emerging role of epigenetics in pulmonary arterial hypertension: an important avenue for clinical trials (2015 Grover Conference Series)Treatment-related biomarkers in pulmonary hypertension Metabolic Syndrome and the Lung New Biochemical Insights into the Mechanisms of Pulmonary Arterial Hypertension in Humans Saudi guidelines on the treatment and management of pulmonary hypertension 2014: Updates a fresh understanding of pulmonary vascular diseases in the developing world.Significance of pulmonary arterial pressure as a prognostic indicator in lung-dominant connective tissue disease.Pulmonary hypertension and the right ventricle-thinking outside the box (Third International Right Heart Failure Summit, part 1).Building the case for novel clinical trials in pulmonary arterial hypertension Soluble guanylate cyclase: a new therapeutic target for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.Neonatal hyperoxic lung injury favorably alters adult right ventricular remodeling response to chronic hypoxia exposure Current clinical management of pulmonary arterial hypertension Update in Pulmonary Vascular Diseases 2014.Effect of Age on Phenotype and Outcomes in Pulmonary Arterial Hypertension Trials.Novel methods in pulmonary hypertension phenotyping in the age of precision medicine (2015 Grover Conference series).Pulmonary Hypertension Associated with Idiopathic Pulmonary Fibrosis: Current and Future Perspectives.Enhancing Insights into Pulmonary Vascular Disease through a Precision Medicine Approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop Report.Pharmacological treatment of HIV-associated pulmonary hypertension.Echocardiography in the Assessment of Patients with Rheumatologic Diseases.Pulmonary arterial hypertension - progress in understanding the disease and prioritizing strategies for drug development.Bone Morphogenic Protein Type 2 Receptor Mutation-Independent Mechanisms of Disrupted Bone Morphogenetic Protein Signaling in Idiopathic Pulmonary Arterial Hypertension.Isolated heart model demonstrates evidence of contractile and diastolic dysfunction in right ventricles from rats with sugen/hypoxia-induced pulmonary hypertension.Is pulmonary hypertension a metabolic disease?Admission for COPD Exacerbation Is Associated with the Clinical Diagnosis of Pulmonary Hypertension: Results from a Retrospective Longitudinal Study of a Veteran Population.PVDOMICS: A Multi-Center Study to Improve Understanding of Pulmonary Vascular Disease Through Phenomics.Mitochondrial dysfunction and pulmonary hypertension: Cause, Effect or Both.Pulmonary Hypertension and Precision Medicine through the "Omics" Looking Glass.Challenges in Pulmonary Hypertension: Controversies in Treating the Tip of the Iceberg.S100A12 as a marker of worse cardiac output and mortality in pulmonary hypertension.Randomized controlled trials: a solid platform for observational research.A Retrospective Review of Infants Receiving Sildenafil.

P2860

Q26766294-D5192D96-60FD-4BC3-BC86-49ECE7FEA69B Q28069443-1CA9D518-D57A-40A9-8308-36DA6678B8B1 Q28081276-CF8B89C0-8C40-497E-994C-3A8241499BA3 Q28384152-8AB36DED-EEBB-4564-BA8C-FF568CA95BA6 Q28553362-055A366B-607F-472E-9A73-CBF92B278D62 Q33815340-F2C63E59-7C79-42FE-BAA9-26C0F6E98642 Q34277188-C8A32B5B-18E6-4BC0-A99C-DF72F49F8C68 Q34782622-6906DC7D-B794-4C60-83B6-04483AFB5618 Q35005853-773F0AFE-F538-423C-8E60-E41BB5ABEDB8 Q35075847-76DEA64B-23F1-4DD7-ACBB-1A617A91F909 Q35437442-31FE87FC-7081-402A-A693-1FC497514C00 Q35673783-C55F43DE-3479-4945-ADE9-3BEE7CF083A1 Q36128639-7B09778F-ED44-449E-A490-AB64536355BB Q37094698-CF1C5925-6B50-48A5-8D60-5E2A8EC26546 Q37555447-D5459D6F-501C-4FCA-A41C-CADA53A5A512 Q37668859-7917F296-D756-4EFF-9794-750CEB79F2AD Q38403596-6D92C0C2-F437-41A7-BA2A-BE9B3BA0D500 Q38728500-C31D45C4-8D67-4365-8EA1-916AA6A8084A Q38866037-EBE99207-655E-4F43-9001-CC1E3A2CE311 Q39317865-D3A4E913-9F87-4CDF-A96E-FF0D33663BA0 Q39760107-AD91A936-6D1F-4E91-AFDB-8D1C30F8A93A Q42378092-5A6B3532-5387-407D-9444-99089A4D61B9 Q43111739-EC1FFC4A-FF32-4F89-A57B-DDE561C2B700 Q45326440-4D476CBC-ED4C-4B6D-85F0-EAF86CBF3169 Q47232759-2E393122-4A11-4CB9-8A96-9470159686B4 Q47726007-54226AF7-38DC-4FEC-9896-B1BC54BAC24C Q47862026-13F8BCFA-19FF-4C52-B9CF-F2E32C9E56B6 Q50098235-6ECFC9F3-6755-4D0B-A378-2A22CC6333F3 Q52610998-5949D7F9-06E8-46F1-8439-A6981355952C Q53786641-BC653573-3F19-4220-8DD0-11CDBA1CE28A Q54968633-C2278AF5-CDB9-44CC-AF91-8E10B9980566

P2860

An official American Thoracic Society Statement: pulmonary hypertension phenotypes

http://www.wikidata.org/entity/Q34919733

description

2014 nî lūn-bûn

@nan

2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

An official American Thoracic Society Statement: pulmonary hypertension phenotypes

@ast

An official American Thoracic Society Statement: pulmonary hypertension phenotypes

@en

An official American Thoracic Society Statement: pulmonary hypertension phenotypes

@nl

type

label

An official American Thoracic Society Statement: pulmonary hypertension phenotypes

@ast

An official American Thoracic Society Statement: pulmonary hypertension phenotypes

@en

An official American Thoracic Society Statement: pulmonary hypertension phenotypes

@nl

prefLabel

An official American Thoracic Society Statement: pulmonary hypertension phenotypes

@ast

An official American Thoracic Society Statement: pulmonary hypertension phenotypes

@en

An official American Thoracic Society Statement: pulmonary hypertension phenotypes

@nl

P1433

Q34919733-828D1A81-8171-4BFC-9E4C-CAD24465BABB

P1476

Q34919733-CC336596-51C2-4BFC-89A2-F29DBF726D05

P2093

Q34919733-0D9D1163-B0A5-48C9-8ABC-D745C7146A1F

Q34919733-2448FDD3-B9A8-4B33-B489-FBCA34D310BC

Q34919733-3F8B18B9-6D1C-40E5-A576-E7E1DD60E2EE

Q34919733-3FD3AF85-1797-4838-A2AE-7DC9AC7B5C66

Q34919733-62244BA6-F3AB-4477-9156-40B6263D8567

Q34919733-63C2AC85-F88B-4FA1-9AA0-CB605902842A

Q34919733-7D78CDCD-DF85-4722-A2E8-A8D4B058D048

Q34919733-AB04EBF5-D0ED-4838-B002-B53A35D7C93B

Q34919733-AC2B56BB-3ADA-4AED-875D-6C7786D9FF09

Q34919733-B6BB16B0-6E5E-4A8A-ACFB-1F0C2B8482A2

P2860

Q34919733-0179ECCD-5FF4-42C0-825B-E3BEC98C18C8

Q34919733-0235121A-A893-4C25-922C-FEEDF324DCC4

Q34919733-02D7A858-36BC-4A4E-B8C1-7AC6B6AA05AF

Q34919733-0309443A-522F-4FCF-8B63-C50846C4704F

Q34919733-032A7081-8A0D-4370-BA90-403BC3B0105B

Q34919733-051E1D37-233D-4DA3-9641-05B07CB13109

Q34919733-058BDBE3-9CB2-4DD9-8A26-A7961091DD71

Q34919733-06950A2C-5A88-4C6D-88EB-A0BA0E65E5D2

Q34919733-0A1881C1-2157-44F9-AFCB-AC8B5CDC3F0D

Q34919733-0ACAB443-CEAA-4B1C-A738-DD5628B9FD28

P304

Q34919733-2BAC6A8A-297E-46A1-9E2D-BCE2A5507210

P31

Q34919733-6B84266D-DE9B-48B7-AC8A-BD377C1DF577

P356

Q34919733-CA288603-EF5D-43F6-B57D-951885142E99

P407

Q34919733-26451B6C-FB71-4125-9C4B-A826EA6A02EB

P433

Q34919733-C4B58C4E-10EA-401C-81B6-FB9CF04D2E37

P478

Q34919733-FAD6860E-2C40-4FB1-BF0A-601423856178

P50

Q34919733-48BA5620-6CEB-48A4-8D03-91D1ED9ADAFD

Q34919733-5CDFAC87-1604-4CB7-994F-8AE94C562B4C

Q34919733-E9750124-54CB-4D96-A4AC-0B0A5C895DB5

P577

Q34919733-C3D3ABBD-6823-4F5D-A173-C3E6468C8D5E

P698

Q34919733-2BFABC68-B2DC-4A8C-9CBA-30D0FB3F2414

P932

Q34919733-232D2A82-375B-4C01-894E-7078AD3F99C1

P356

RCCM.201311-1954ST

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

An official American Thoracic Society Statement: pulmonary hypertension phenotypes

@en

P2093

ATS Committee on Pulmonary Hypertension Phenotypes

http://www.w3.org/2001/XMLSchema#string

Evangelos Michelakis

http://www.w3.org/2001/XMLSchema#string

Karen Fagan

http://www.w3.org/2001/XMLSchema#string

Kurt Stenmark

http://www.w3.org/2001/XMLSchema#string

Michael Krowka

http://www.w3.org/2001/XMLSchema#string

Nicholas S Hill

http://www.w3.org/2001/XMLSchema#string

Paul M Hassoun

http://www.w3.org/2001/XMLSchema#string

Raed A Dweik

http://www.w3.org/2001/XMLSchema#string

Rubin M Tuder

http://www.w3.org/2001/XMLSchema#string

Serpil C Erzurum

http://www.w3.org/2001/XMLSchema#string

P2860

Combined pulmonary fibrosis and emphysema syndrome: a review

Nitric oxide in adaptation to altitude

Clinical classification of pulmonary hypertension.

Updated clinical classification of pulmonary hypertension.

HIV-Related pulmonary hypertension: analytic review of 131 cases.

Clinical features of paediatric pulmonary hypertension: a registry study

High-altitude disorders: pulmonary hypertension: pulmonary vascular disease: the global perspective.

Clinical risk factors for portopulmonary hypertension.

Hypoxia inducible-factor1alpha regulates the metabolic shift of pulmonary hypertensive endothelial cells.

Determinants of right ventricular ejection fraction in pulmonary arterial hypertension.

P304

345-355

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.201311-1954ST

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

189

http://www.w3.org/2001/XMLSchema#string

P50

Nicholas W Morrell

P577

2014-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24484330

http://www.w3.org/2001/XMLSchema#string

P932

4291177

http://www.w3.org/2001/XMLSchema#string